Not for distribution to U.S. Newswire Services or for dissemination in the United States of America. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.
CALGARY, AB / ACCESSWIRE / August 7, 2020 / Sparta Group (TSXV:SAY) (the “Corporation” the “Company“, “Sparta Group“, “Sparta Capital” or “Sparta“) has signed a distribution agreement with SBL Technologies Incorporated (“SBL“), paving the way to supply fast COVID-19 antibody testing and analysis for truckers who are putting their lives at risk every day.
In a July 16, 2020 news release, Sparta announced that its “TruckSuite™ Canada division had assembled an exclusive, symbiotic suite of COVID-19 safety tools to assist the trucking industry”. As an important component of that suite, “COVID-19 testing for truckers” was to be added; and thus, this agreement becomes the cornerstone of the testing program.
With headquarters in both Calgary and Austin, Texas, SBL is a well-established provider of on-site rapid testing technologies and support tools to help employers manage risk and maintain worker safety. SBL’s COVID-19 Antibody Rapid Test can determine whether a person has contracted the SARS-CoV-2 virus and is actively producing IgM antibodies. In addition, it can indicate if a patient who may have previously contracted the virus and has since recovered, still has the disease-fighting IgG antibodies in their system. The rapid antibody tests can provide valuable information for contact tracing, which can pinpoint who else is at risk of infection, on-site, within fifteen minutes.
Under the terms of the agreement, Sparta will be able to start distributing the FDA Emergency Use Authorized (“EUA”) COVID-19 Antibody Rapid Test Kits to truckers in the United States and will have full access to support from SBL, including laboratory testing and training on administration and interpreting results. Additionally, Sparta will have access to a dedicated mobile reporting App so that results can be monitored anywhere in real time and can be further integrated into the additional tracking Apps being assembled as part of the TruckSuite™ safety tools.
“The Antibody Rapid Test Kit is part of our TruckSuite™ division’s COVID-19 Safety Program and can be very helpful when addressing front line workers like our truckers. With an industry as large as trucking, that employs more than 8.7 million workers across America, it really helps to be able to gather data so that we can improve strategies to curb the COVID-19 pandemic and make sure that truckers on the frontlines are safe. SBL is known for providing high quality tests to enterprise companies across a variety of industries, such as the energy, mining, manufacturing and agriculture sectors. We are pleased to be working alongside them as we now expand into the very important transport vertical.” said Sparta President, John O’Bireck.
The suite of COVID-19 safety tools will be branded through the company’s TruckSuite™ division, which was originally designed to look after the health of trucks but given the unusual times we are living in, has been extended to the health of truckers as well. On July 23, 2020 Sparta also issued a news release announcing a licensing agreement to distribute and co-develop a package of nanotechnology formulations aimed at killing harmful pathogens on the drivers and in their cabs. The Antibody Rapid Test Kits are an equally important part of the Sparta trucker safety program.
About SBL
With headquarters in Calgary, Alberta and Austin, Texas, SBL Testing Technologies is a provider of on-site rapid testing technologies and comprehensive support for workplaces to manage risk. SBL has partnerships with leading manufacturers worldwide to offer its clients the highest quality in workplace testing available, along with training and customized support services. You can learn more about SBL testing technologies through the following video link: SBL technology and by visiting www.sbltt.com.
About Sparta
Sparta Group (a.k.a. Sparta Capital Ltd.) is a technology-based company that owns or holds a controlling interest in a network of independent businesses that supply energy saving technologies designed to reduce energy inefficiencies, achieve reduced emissions and increase operating efficiencies in various industries. In response to the COVID-19 crisis, Sparta has also expanded its scope to help facilitate supply of necessary materials while assisting talented inventors who are looking to introduce innovative technical solutions that will bring greater normalcy to the post COVID-19 world. Sparta’s network of independent businesses provides a wide range of specialized energy capturing, converting, optimizing, and related services to the commercial sector. Sparta provides capital, technical and engineering expertise, legal support, financial and accounting knowledge, strategic planning and other shared services to its independent businesses.
Sparta is a publicly traded company listed on the TSX Venture Exchange under the symbol “SAY“. Additional information is available on our website at www.spartagroup.ca or on SEDAR at www.sedar.com
For more information contact:
John O’Bireck, President & CTO
Email: jobireck@spartagroup.ca
Telephone: (905) 751-8004
Cautionary Statements:
This above may contain “forward-looking information” within the meaning of applicable securities laws. When used in this address, the words “estimate”, “project”, “belief”, “anticipate”, “intend”, “expect”, “plan”, “predict”, “may” or “should” and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. Although the Corporation believes in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate that the expectations reflected in this forward-looking information are reasonable, readers are cautioned to not place undue reliance on forward-looking information because the Corporation can give no assurance that they will prove to be correct. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date of publication of this information and the Corporation undertakes no obligation to update such forward-looking statements if these beliefs, estimates and opinions or other circumstances should change. Furthermore, the Corporation undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of the Corporation. All forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release).
SOURCE: Sparta Group
View source version on accesswire.com:
https://www.accesswire.com/600687/Sparta-Secures-Agreement-to-Provide-COVID-19-Antibody-Testing-to-Trucking-Industry
Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…